In the past year, the business community reported that continuous changes in the global market have had a lasting impact on the global pharmaceutical market. The developed markets in Europe and the United States have contributed to the growth of global pharmaceutical growth, while the pharmaceutical markets in China, Brazil, Russia, India, Mexico, Turkey and South Korea have performed outstandingly and have strong growth potential and market prospects. This trend will become the benchmark for the future development of the industry.
According to the market forecast report of IMS released in June 2010 for the global pharmaceutical market from 2010 to 2014, the annual compound annual growth rate from 2010 to 2014 was only 6.2%, compared with the previous five years (2004). -Comparative growth rate of 6.7% from 2009 to 2009, a decrease of 0.5%.
Although North America will continue to be the largest contributor to the global pharmaceutical market in 2014, its global market share will decline from 38% in 2009 to 35% in 2014, while the global market share in South and East Asia will be from 2009. The 7% increase to 12% in 2014.
The South Asian and East Asian markets continue to expand in the global market. Five of the 17 pharmaceutical emerging markets defined by IMS all belong to the Asian market. China is the leader in the contribution to global economic growth and the only country in the first group of emerging medicine markets, and India also has a place in the second group of newly emerging pharmaceutical markets with only three countries (see Table 1). In the next five years, these 17 countries or regions will become the largest contributors to the world's pharmaceutical sales growth, and more than 45% of global growth will come from these emerging pharmaceutical markets.
The IMS global market forecast report shows that China will become the main force of regional economic growth, and its compound annual growth rate will reach 23.2% in the next five years, while India and South Korea will also be at a compound annual growth rate of 14.8% and 10.2% respectively. Live later. From the treatment field analysis, anti-infectives, digestive tract and metabolism, and cardiovascular drugs will continue to maintain their position as the largest market share contributors within the Southeast Asian and East Asian pharmaceutical markets.
According to the market forecast report of IMS released in June 2010 for the global pharmaceutical market from 2010 to 2014, the annual compound annual growth rate from 2010 to 2014 was only 6.2%, compared with the previous five years (2004). -Comparative growth rate of 6.7% from 2009 to 2009, a decrease of 0.5%.
Although North America will continue to be the largest contributor to the global pharmaceutical market in 2014, its global market share will decline from 38% in 2009 to 35% in 2014, while the global market share in South and East Asia will be from 2009. The 7% increase to 12% in 2014.
The South Asian and East Asian markets continue to expand in the global market. Five of the 17 pharmaceutical emerging markets defined by IMS all belong to the Asian market. China is the leader in the contribution to global economic growth and the only country in the first group of emerging medicine markets, and India also has a place in the second group of newly emerging pharmaceutical markets with only three countries (see Table 1). In the next five years, these 17 countries or regions will become the largest contributors to the world's pharmaceutical sales growth, and more than 45% of global growth will come from these emerging pharmaceutical markets.
The IMS global market forecast report shows that China will become the main force of regional economic growth, and its compound annual growth rate will reach 23.2% in the next five years, while India and South Korea will also be at a compound annual growth rate of 14.8% and 10.2% respectively. Live later. From the treatment field analysis, anti-infectives, digestive tract and metabolism, and cardiovascular drugs will continue to maintain their position as the largest market share contributors within the Southeast Asian and East Asian pharmaceutical markets.
Silicone Cleanser Brush,Cleansing Silicone Brush,Best Silicone Cleansing Brush,Silicone Facial Cleansing Brush
Shenzhen Jie Zhong Lian Investment Co., Ltd. , https://www.szmeizonscare.com